More News

Base to Base biotech podcast 77: Transferring mammal traits to humans, and a new way to kill cancer?

Jim Cornall -
This week, we chat with Evan Appleton, chief scientific officer and co-founder of Intertwined, a company focused on understanding...

New possibilities for Alzheimer’s treatment by restoring brain immune balance

Jim Cornall -
Minah Suh of the Department of Biomedical Engineering at Sungkyunkwan University, in collaboration with the biotechnology company IMNEWRUN and...

Insilico launches AI-driven longevity vaccines research

Jim Cornall -
Insilico Medicine has launched Longevity Vaccines, a research initiative developing treatments that direct a patient’s own immune cells to...

KAIST finds a way to redirect cell state with single stimulus

Jim Cornall -
A Korean research team has developed a general-purpose computational framework that identifies the key targets needed to steer a...

Sling Therapeutics raises $123m for phase 3 thyroid eye disease study

Jim Cornall -
Sling Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye...

Cracking the genetic code of psoriasis

Jim Cornall -
A research team has revealed the specific mechanisms behind the onset of psoriasis by combining large-scale genomic data from...

FDA approves drug for SMA

Jim Cornall -
Cure SMA, a nonprofit organisation supporting those impacted by spinal muscular atrophy (SMA) has reacted positively to the news...

Big Picture Bio founded to work on promising cancer combination therapies

Jim Cornall -
Big Picture Bio Ltd., has been founded to identify, design and optimise promising cancer combination therapies, using a generative...

Earlier asthma diagnosis could bring relief

Jim Cornall -
Blowing into a tube to diagnose asthma is not easy for babies or toddlers. Babies and young children suspected of...

Stem cells can contribute to new treatments for heart attacks and Parkinson’s

Jim Cornall -
Cells from nine “super donors” are being collected in Oslo. The aim is for these to be used to...

FDA okays IND application for familial adenomatous polyposis drug

Jim Cornall -
Sapience Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted the company an Investigational...

NTDpedia launched to fight neglected tropical diseases

Jim Cornall -
The Global Health Innovative Technology (GHIT) Fund has launched NTDpedia: Your Guide to Neglected Tropical Diseases. Designed as an accessible,...

Base to Base biotech podcast 76: Early disease detection and beating CNS cancers

Jim Cornall -
This week, we have conversations with Marc Hedrick, CEO of Cerenome, about a combined approach to tackling central nervous...

‘Positive trends’ from phase 2 amyotrophic lateral sclerosis trial

Jim Cornall -
Axoltis Pharma has announced topline results of SEALS, its phase 2 clinical trial evaluating the effect of NX210c in...

Successful results from trial of first-in-class Parkinson’s disease peptide

Jim Cornall -
Teitur Trophics, a biotechnology company developing novel neuroprotective peptides for neurodegenerative diseases, has announced successful results from its phase...

Researchers uncover how neurons deliver RNA where it is needed

Jim Cornall -
KAIST says a research team led by Ki-Jun Yoon of the Department of Biological Sciences has identified a mechanism...

Revvity to acquire Human Cell Design

Jim Cornall -
Revvity, Inc. has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specialising...

Engineered immune cells trial to fight colorectal cancer approved

Jim Cornall -
The U.S. Food and Drug Administration has granted permission for investigators at the University of Colorado Anschutz to conduct...

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

Jim Cornall -
Elix, Inc. and Axcelead Drug Discovery Partners, Inc. have entered into a collaborative research agreement aimed at the discovery...

Lotus Neuro launches to deliver therapies across blood-brain barrier

Jim Cornall -
Lotus Neuro, a clinical-stage biotechnology company pairing focused ultrasound with leading therapeutic modalities to treat focal neurologic disease, has...

Antibody targeting TSLP achieves positive results in asthma study

Jim Cornall -
Harbour BioMed has announced that its partner, Windward Bio, has reported positive interim results from the phase 2 portion...